Abstract: The present invention relates to methods for enhancing, extending and accelerating the cosmetic benefits certain non-surgical dermal interventions, examples of which include treatment with aesthetic injectables such as botulinum toxin and dermal fillers, as well as intense pulsed light (IPL) treatments, particularly cosmetic treatments characterized by the injection of botulinum toxin compositions, such as Botox® and Dysport®, and/or dermal fillers, such as Restylane® and Juviderm®. More particularly, the present invention relates to the unexpected discovery that the combination of micron-sized particulate bioactive glass and medical grade hyaluronic acid yields a cosmetic composition that is capable of improving and prolonging the anti-wrinkle effects of such cosmetic therapies as well as to afford enhanced and improved healing and anti-microbial benefits at the site(s) of injection.

Abstract: The present invention relates to methods for enhancing, extending and accelerating the cosmetic benefits certain non-surgical dermal interventions, examples of which include treatment with aesthetic injectables such as botulinum toxin and dermal fillers, as well as intense pulsed light (IPL) treatments, particularly cosmetic treatments characterized by the injection of botulinum toxin compositions, such as Botox® and Dysport®, and/or dermal fillers, such as Restylane® and Juviderm®. More particularly, the present invention relates to the unexpected discovery that the combination of micron-sized particulate bioactive glass and medical grade hyaluronic acid yields a cosmetic composition that is capable of improving and prolonging the anti-wrinkle effects of such cosmetic therapies as well as to afford enhanced and improved healing and anti-microbial benefits at the site(s) of injection.

Abstract: The present invention relates to methods and compositions for inhibiting, treating, and preventing dental diseases in human and non-human animals, particularly domesticated companion animals. More particularly, the present invention relates to the unexpected discovery that the combination of micron-sized particulate bioactive glass and a topical bisphosphonate yields a composition that is capable of treating and/or preventing dental problems such as periodontal disease, tooth decay and tooth resorption in animals, particularly small mammals such as cats.

Abstract: The present invention relates to methods and compositions for inhibiting, treating, and preventing dental diseases in human and non-human animals, particularly domesticated companion animals. More particularly, the present invention relates to the unexpected discovery that the combination of micron-sized particulate bioactive glass and a topical bisphosphonate yields a composition that is capable of treating and/or preventing dental problems such as periodontal disease, tooth decay and tooth resorption in animals, particularly small mammals such as cats.

Abstract: The present invention relates to methods and compositions for inhibiting, treating, and preventing dental diseases in human and non-human animals, particularly domesticated companion animals. More particularly, the present invention relates to the unexpected discovery that the combination of micron-sized particulate bioactive glass and a topical bisphosphonate yields a composition that is capable of treating and/or preventing dental problems such as periodontal disease, tooth decay and tooth resorption in animals, particularly small mammals such as cats.

Abstract: Methods for whitening teeth including contacting teeth with an effective amount of particulate bioactive glass are disclosed.

Abstract: A novel silica based bioactive glass composition that can be used in conjunction with a delivery agent such as a toothpaste, gel saliva, etc. having a particle size range <90 &mgr;m which will form a rapid and continuous reaction with body fluids due to the immediate and long term ionic release of Ca and P from the core silica particles, to produce a stable crystalline hydroxy carbonate apatite layer deposited onto and into the dentin tubules for the immediate and long term reduction of dentin hypersensitivity.

Abstract: A novel silica based bioactive glass composition that can be used in conjunction with a delivery agent such as a toothpaste, gel, etc. having a particle size range <90 &mgr;m which will form a rapid and continuous reaction with body fluids due to the immediate and long term ionic release of Ca and P from the core silica particles, to produce a stable crystalline hydroxy carbonate apatite layer deposited onto and into the dentin tubules for the immediate and long term reduction of dentin hypersensitivity and tooth surface remineralization.

Abstract: A novel silica based bioactive glass composition that can be used in conjunction with a delivery agent such as a toothpaste, gel, etc. having a particle size range <90 .mu.gm which will form a rapid and continuous reaction with body fluids due to the immediate and long term ionic release of Ca and P from the core silica particles, to produce a stable crystalline hydroxy carbonate apatite layer deposited onto and into the dentin tubules for the immediate and long term reduction of dentin hypersensitivity and tooth surface remineralization.

Abstract: A novel silica based bioactive glass composition that can be used in conjunction with a delivery agent such as a toothpaste, gel saliva, etc. having a particle size range <90 .mu.m which will form a rapid and continuous reaction with body fluids due to the immediate and long term ionic release of Ca and P from the core silica particles, to produce a stable crystalline hydroxy carbonate apatite layer deposited onto and into the dentin tubules for the immediate and long term reduction of dentin hypersensitivity.